REG - Hellenic Dynamics - First Day of Dealings

Hellenic DynamicsAnnouncement

05/12/2022 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221205:nRSE5232Ia&default-theme=true

RNS Number : 5232I  Hellenic Dynamics PLC  05 December 2022

05 December 2022

THIS ANNOUNCEMENT, INCLUDING THE INFORMATION CONTAINED IN IT IS RESTRICTED AND
IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN
WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA,
JAPAN, OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH
PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. PLEASE SEE THE
IMPORTANT NOTICE WITHIN THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES
OR ANY OTHER JURISDICTION. INVESTORS SHOULD NOT SUBSCRIBE FOR OR PURCHASE ANY
SECURITIES REFERRED TO IN THIS ANNOUNCEMENT EXCEPT ON THE BASIS OF INFORMATION
IN THE ADMISSION DOCUMENT PUBLISHED BY HELLENIC DYNAMICS PLC IN CONNECTION
WITH THE PROPOSED ADMISSION OF ITS ORDINARY SHARES TO TRADING ON THE LONDON
STOCK EXCHANGE.

 

 

Hellenic Dynamics Plc

(Formerly U.K. SPAC Plc)

("Hellenic Dynamics" or the "Company")

 

Admission to the London Stock Exchange

and

First Day of Dealings

Hellenic Dynamics Plc (formerly U.K. SPAC Plc) announces that admission of the
Company's ordinary shares to trading on London Stock Exchange ("Admission")
will take place and dealings will commence at 8.00 a.m. today under the ticker
HELD (ISIN: GB00B3CQW227).

Highlights

The Company has raised gross proceeds of £1.125 million through a fundraising
where the number of subscribers exceeded the number of shares on offer.

Hellenic Dynamics plans to cultivate and export THC dominant medical cannabis
products to the 25 countries in Europe that now allow medicinal cannabis for
patients via prescription.

The European cannabis market is expected to reach €37 billion by 2027, twice
the size of the Canadian and North American markets combined.

Hellenic Dynamics operates from a 195,506 square meter facility in northern
Greece, which in full production is capable of producing over 54,000kg of
dried medical cannabis flowers per annum. The facility benefits from low power
costs as well as local, competitive skilled and semi-skilled labour rates.

For the next 12 months, the Company will continue to its core strategic
objectives, which are to fulfil two term sheets for offtake of THC dominant
medical cannabis products into Germany's advanced medical cannabis market,
secure further supply lines into the UK, increase total cultivation area in
line with the European cannabis demand.

At Admission, the Company will acquire Hellenic Dynamics S.A. for
consideration of £31,243,342.59. The consideration is being satisfied by the
issue of 10,414,447,530 new ordinary shares in the Company at the price of 0.3
pence per share. In conjunction with Admission, the Company has raised gross
proceeds of £1.125 million through a fundraising that is comprised of a
£750,000 subscription and a £375,000 convertible loan note, both at an issue
price of 0.3 pence per share. Peterhouse Capital Limited acted as Financial
Advisers to the transaction.

 

Davinder Rai, CEO of Hellenic Dynamics, commented:

"Today marks an important milestone not just for Hellenic Dynamics, but
for millions of patients across Europe who are looking to be prescribed
THC dominant medical cannabis. At the beginning of this pioneering
transaction both the directors of Hellenic and UK SPAC knew we were forging
new tracks for the FCA, and the London Stock Exchange and today's Admission
is testament to the entire transaction team.

Hellenic Dynamics is more committed than ever in its ambition to be the
dominant supplier of high quality and competitively priced dried medical
cannabis flowers to patients across all 25 European counties that allow
medical cannabis by prescription"

 

For the purposes of the Financial Conduct Authority's Disclosure Guidance and
Transparency Rules, on admission the Company will have 12,530,000,000 ordinary
shares of 0.1 pence each in issue, each share carrying the right to one vote.
The figure of 12,530,000,000 should be used by shareholders in the Company as
the denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
Company under the Financial Conduct Authority's Disclosure Guidance and
Transparency Rules.

 

For further information, please refer to the full prospectus published at
https://data.fca.org.uk/artefacts/NSM/Portal/NI-000063506/NI-000063506.pdf
(https://data.fca.org.uk/artefacts/NSM/Portal/NI-000063506/NI-000063506.pdf)
or contact the following:

 

Hellenic Dynamics Plc (formerly known as UK SPAC Plc)

Tel: +44 (0)203 818 7850

Davinder Rai

 

Cairn Financial Advisers LLP

Tel: +44 (0)20 7213 0880

Jo Turner / Sandy Jamieson

 

Peterhouse Capital Limited (Corporate Broker)

Tel: +44 (0)20 7469 0930

Guy Miller / Charles Goodfellow

 

 

Market Abuse Regulation (MAR) Disclosure

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation EU 596/2014 as it forms part of retained EU law
(as defined in the European Union (Withdrawal) Act 2018).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  LISUPGRCPUPPPPC